Citi Pharma Gets CCP Approval to Acquire 100% Stake in Pakheim International Pharma
The Competition Commission of Pakistan has approved Citi Pharma’s acquisition of Pakheim International Pharma, clearing the transaction after finding no significant competition concerns.
Citi Pharma Gets CCP Approval for 100% Acquisition of Pakheim International Pharma
Citi Pharma has received Competition Commission of Pakistan approval to acquire 100% of Pakheim International Pharma, advancing its expansion plans and pharmaceutical manufacturing strategy.
Pakistan and China Sign Over 120 Healthcare Agreements Valued Above 1.7 Billion Dollars
Pakistani and Chinese enterprises sign more than 120 agreements worth over 1.7 billion dollars at a high level healthcare and biotechnology conference in Islamabad.